Loading…
Seoul Pharmaceutical completed the relocation of its facilities from Siheung to the expanded Osong plant, enabling integrated production of all dosage forms starting July 2017.
Seoul Pharmaceutical announced a 10-year contract to supply its tadalafil orally disintegrating film (ODF) product to Chinese company GHC, valued at approximately 1,111 billion won ($97.25 million).
| Site | Largest | Latest |
|---|---|---|
| Osong, South Korea | 2017-07-01 |